| Phase 3 |
| NCT03126916 |
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With… |
Ganglioneuroblastoma |
Recruiting |
| NCT06022939 |
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone… |
AL Amyloidosis |
Recruiting |
| NCT06172296 |
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of… |
Ganglioneuroblastoma, Nodular |
Recruiting |
| NCT02443077 |
Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or… |
Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type |
Active, Not Recruiting |
| NCT00114101 |
Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell… |
DS Stage I Multiple Myeloma |
Active, Not Recruiting |
| NCT07624513 |
Determination 2 - Isatuximab, Iberdomide, Bortezomib and Dexamethasone Induction… |
Multiple Myeloma |
Not Yet Recruiting |
| NCT00602641 |
Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly… |
Multiple Myeloma |
Active, Not Recruiting |
| Phase 2 |
| NCT04370301 |
Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or… |
Primary Myelofibrosis |
Recruiting |
| NCT03579875 |
Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders |
Fanconi Anemia |
Recruiting |
| NCT06028828 |
Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation |
Allogeneic Hematopoietic Stem Cell Transplantation |
Recruiting |
| NCT05504291 |
A Study to Give Treatment Inside the Eye to Treat Retinoblastoma |
Bilateral Retinoblastoma |
Recruiting |
| NCT06207799 |
Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With… |
Multiple Myeloma |
Recruiting |
| NCT07228624 |
Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With… |
Myelodysplastic/Myeloproliferative Neoplasm |
Recruiting |
| NCT01804634 |
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors |
Refractory and/or Relapsed Metastatic Solid Tumors |
Recruiting |
| NCT05735717 |
MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies |
Hematologic Malignancy |
Recruiting |
| NCT06679829 |
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an… |
Multiple Myeloma |
Recruiting |
| NCT02727803 |
Personalized NK Cell Therapy in CBT |
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive |
Recruiting |
| NCT05564390 |
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study… |
Acute Myeloid Leukemia |
Recruiting |
| NCT03674411 |
Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy |
Acute Myeloid Leukemia |
Active, Not Recruiting |
| NCT04395222 |
Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation |
Hematologic Malignancy |
Active, Not Recruiting |
| NCT06001385 |
HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced… |
Acute Lymphoblastic Leukemia |
Active, Not Recruiting |
| NCT00716066 |
Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases |
Autoimmune Disease |
Active, Not Recruiting |
| NCT05565105 |
CD34+ Transplants for Leukemia and Lymphoma |
Leukemia, Myeloid, Acute |
Not Yet Recruiting |
| NCT04904588 |
HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With… |
Acute Lymphoblastic Leukemia |
Active, Not Recruiting |
| NCT04384692 |
Peritransplant Ruxolitinib for Patients With Primary and Secondary Myelofibrosis |
Primary Myelofibrosis |
Active, Not Recruiting |